RUNX1::RUNX1T1 made EGR1 overexpressed to inhibit cell proliferation and promoted apoptosis, which has a relatively favorable outcome in RUNX1::RUNX1T1-positive AML (10). Here, RUNX1T1 is linked to acute myeloid leukemia.